Need Help?
Join Our Mailing ListThe following represents the content we have available in
this category:
 |
Multi-strain influenza vaccine passes first phase of clinical trials 
Researchers from the University of Texas at Galveston are gearing up to present their findings in October at the Conference on Agents and Chemotherapy and the Infectious Disease Society of America. Their work, underwritten by a grant from the Bill and Melinda Gates Foundation, has led to a multi-strain influenza vaccine that has passed the first phase of clinical trials. |
|
Official U.S. Government Web site for Information on Pandemic Flu and Avian Influenza
|